Implications for Big Pharma Pipelines

China has emerged as a big player in biotechnology, and major drugmakers and investors are catching on. WSJ reporter Peter Loftus tells us how China surged ahead in the biotech race, and why big pharma sees it as an opportunity. Plus, WSJ reporter Kate Clark introduces us to the whiz kids who dropped out of college to pursue their AI dreams—and are getting investors to pay their bills. Belle Lin hosts.

Sign up for the WSJ's free Technology newsletter.

Learn more about your ad choices. Visit megaphone.fm/adchoices